EMA : RECOMMENDS MARKETING AUTHORISATION FOR FOUNDAYO (ORFORGLIPRON) ORAL GLP-1 FOR WEIGHT MANAGEMENT AND TYPE 2 DIABETES

Reuters · 2d ago

Please log in to view news